Literature DB >> 19563878

Attenuated expression of SECIS binding protein 2 causes loss of telomeric reserve without affecting telomerase.

Jeffery E Squires1, Philip Davy, Marla J Berry, Rich Allsopp.   

Abstract

The family of selenoproteins have a broad range of functions, including protection against oxidative damage. Previous studies have shown that elevated levels of oxidative damage can induce accelerated loss of telomeric DNA during proliferation of mammalian cells. The incorporation of selenocysteine (Sec) into proteins in mammalian cells requires the Sec insertion sequence (SECIS) binding protein 2 (SBP2). Thus in the present study we have assessed the effect of knocking down the expression of SBP2 on telomere length. Following knock-down of SBP2 expression in two different human cell lines, the MSTO mesothelioma cell line ( approximately 5Kb average telomere length) and SY5Y neuroblastoma cell line (approximately 4.2Kb average telomere length), we observed a significant reduction (-0.6 to -1.1 Kb; P <or= 0.01) in telomere length as compared to control cells. This reduction in telomere length was independent of affects on telomerase, since both telomerase activity levels and Tert mRNA expression levels were not altered by knock-down of SBP2 expression. Furthermore, telomeres were particularly sensitive to S1 nuclease digestion following SBP2 knock-down, indicating an increased frequency of oxidative damage-induced lesions in the telomeric DNA in these cells. Together, these observations imply that selenoproteins may help protect telomeric reserve in mammalian cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19563878      PMCID: PMC2735496          DOI: 10.1016/j.exger.2009.06.005

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  20 in total

1.  A telomerase component is defective in the human disease dyskeratosis congenita.

Authors:  J R Mitchell; E Wood; K Collins
Journal:  Nature       Date:  1999-12-02       Impact factor: 49.962

2.  The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability.

Authors:  M T Hemann; M A Strong; L Y Hao; C W Greider
Journal:  Cell       Date:  2001-10-05       Impact factor: 41.582

Review 3.  Telomeres and telomerase: their mechanisms of action and the effects of altering their functions.

Authors:  Elizabeth H Blackburn
Journal:  FEBS Lett       Date:  2005-02-07       Impact factor: 4.124

Review 4.  Cellular senescence: when bad things happen to good cells.

Authors:  Judith Campisi; Fabrizio d'Adda di Fagagna
Journal:  Nat Rev Mol Cell Biol       Date:  2007-09       Impact factor: 94.444

5.  SBP2 binding affinity is a major determinant in differential selenoprotein mRNA translation and sensitivity to nonsense-mediated decay.

Authors:  Jeffrey E Squires; Ilko Stoytchev; Erin P Forry; Marla J Berry
Journal:  Mol Cell Biol       Date:  2007-09-10       Impact factor: 4.272

6.  Long telomeres in the mature human placenta.

Authors:  R Allsopp; J Shimoda; D Easa; K Ward
Journal:  Placenta       Date:  2006-06-23       Impact factor: 3.481

7.  The effect of TERC haploinsufficiency on the inheritance of telomere length.

Authors:  Fred Goldman; Rachida Bouarich; Shashikant Kulkarni; Sara Freeman; Hong-Yan Du; Lea Harrington; Philip J Mason; Arturo Londoño-Vallejo; Monica Bessler
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-11       Impact factor: 11.205

8.  SECIS-SBP2 interactions dictate selenocysteine incorporation efficiency and selenoprotein hierarchy.

Authors:  S C Low; E Grundner-Culemann; J W Harney; M J Berry
Journal:  EMBO J       Date:  2000-12-15       Impact factor: 11.598

Review 9.  From selenium to selenoproteins: synthesis, identity, and their role in human health.

Authors:  Laura Vanda Papp; Jun Lu; Arne Holmgren; Kum Kum Khanna
Journal:  Antioxid Redox Signal       Date:  2007-07       Impact factor: 8.401

10.  The selenoproteome exhibits widely varying, tissue-specific dependence on selenoprotein P for selenium supply.

Authors:  Peter R Hoffmann; Simone C Höge; Ping-An Li; Fukun W Hoffmann; Ann C Hashimoto; Marla J Berry
Journal:  Nucleic Acids Res       Date:  2007-06-06       Impact factor: 16.971

View more
  4 in total

Review 1.  The syndrome of inherited partial SBP2 deficiency in humans.

Authors:  Alexandra M Dumitrescu; Caterina Di Cosmo; Xiao-Hui Liao; Roy E Weiss; Samuel Refetoff
Journal:  Antioxid Redox Signal       Date:  2010-04-01       Impact factor: 8.401

2.  Mutations in the selenocysteine insertion sequence-binding protein 2 gene lead to a multisystem selenoprotein deficiency disorder in humans.

Authors:  Erik Schoenmakers; Maura Agostini; Catherine Mitchell; Nadia Schoenmakers; Laura Papp; Odelia Rajanayagam; Raja Padidela; Lourdes Ceron-Gutierrez; Rainer Doffinger; Claudia Prevosto; Jian'an Luan; Sergio Montano; Jun Lu; Mireille Castanet; Nick Clemons; Matthijs Groeneveld; Perrine Castets; Mahsa Karbaschi; Sri Aitken; Adrian Dixon; Jane Williams; Irene Campi; Margaret Blount; Hannah Burton; Francesco Muntoni; Dominic O'Donovan; Andrew Dean; Anne Warren; Charlotte Brierley; David Baguley; Pascale Guicheney; Rebecca Fitzgerald; Alasdair Coles; Hill Gaston; Pamela Todd; Arne Holmgren; Kum Kum Khanna; Marcus Cooke; Robert Semple; David Halsall; Nicholas Wareham; John Schwabe; Lucia Grasso; Paolo Beck-Peccoz; Arthur Ogunko; Mehul Dattani; Mark Gurnell; Krishna Chatterjee
Journal:  J Clin Invest       Date:  2010-11-15       Impact factor: 14.808

3.  Coordinate regulation between expression levels of telomere-binding proteins and telomere length in breast carcinomas.

Authors:  Kimberly S Butler; William C Hines; Christopher M Heaphy; Jeffrey K Griffith
Journal:  Cancer Med       Date:  2012-07-24       Impact factor: 4.452

4.  Opposing impacts on healthspan and longevity by limiting dietary selenium in telomere dysfunctional mice.

Authors:  Ryan T Wu; Lei Cao; Elliot Mattson; Kenneth W Witwer; Jay Cao; Huawei Zeng; Xin He; Gerald F Combs; Wen-Hsing Cheng
Journal:  Aging Cell       Date:  2016-09-21       Impact factor: 9.304

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.